234 related articles for article (PubMed ID: 10913166)
1. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.
Fenrick R; Wang L; Nip J; Amann JM; Rooney RJ; Walker-Daniels J; Crawford HC; Hulboy DL; Kinch MS; Matrisian LM; Hiebert SW
Mol Cell Biol; 2000 Aug; 20(16):5828-39. PubMed ID: 10913166
[TBL] [Abstract][Full Text] [Related]
2. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
Wang L; Hiebert SW
Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
[TBL] [Abstract][Full Text] [Related]
3. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.
Irvin BJ; Wood LD; Wang L; Fenrick R; Sansam CG; Packham G; Kinch M; Yang E; Hiebert SW
J Biol Chem; 2003 Nov; 278(47):46378-86. PubMed ID: 12960174
[TBL] [Abstract][Full Text] [Related]
4. Tel induces a G1 arrest and suppresses Ras-induced transformation.
Rompaey LV; Potter M; Adams C; Grosveld G
Oncogene; 2000 Nov; 19(46):5244-50. PubMed ID: 11077441
[TBL] [Abstract][Full Text] [Related]
5. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.
Chakrabarti SR; Nucifora G
Biochem Biophys Res Commun; 1999 Nov; 264(3):871-7. PubMed ID: 10544023
[TBL] [Abstract][Full Text] [Related]
6. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor.
Wood LD; Irvin BJ; Nucifora G; Luce KS; Hiebert SW
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3257-62. PubMed ID: 12626745
[TBL] [Abstract][Full Text] [Related]
7. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).
Boccuni P; MacGrogan D; Scandura JM; Nimer SD
J Biol Chem; 2003 Apr; 278(17):15412-20. PubMed ID: 12588862
[TBL] [Abstract][Full Text] [Related]
8. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.
Heibert SW; Lutterbach B; Durst K; Wang L; Linggi B; Wu S; Wood L; Amann J; King D; Hou Y
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S31-4. PubMed ID: 11587363
[TBL] [Abstract][Full Text] [Related]
11. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
12. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.
Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW
Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596
[TBL] [Abstract][Full Text] [Related]
13. Proteins of the ETS family with transcriptional repressor activity.
Mavrothalassitis G; Ghysdael J
Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
[TBL] [Abstract][Full Text] [Related]
14. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.
Jayaraman G; Srinivas R; Duggan C; Ferreira E; Swaminathan S; Somasundaram K; Williams J; Hauser C; Kurkinen M; Dhar R; Weitzman S; Buttice G; Thimmapaya B
J Biol Chem; 1999 Jun; 274(24):17342-52. PubMed ID: 10358095
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.
Lee YJ; Kim JH; Bae S; Rho SK; Choe SY
Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033
[TBL] [Abstract][Full Text] [Related]
16. Reversion of Ras transformed cells by Ets transdominant mutants.
Wasylyk C; Maira SM; Sobieszczuk P; Wasylyk B
Oncogene; 1994 Dec; 9(12):3665-73. PubMed ID: 7970725
[TBL] [Abstract][Full Text] [Related]
17. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
18. TEL is a sequence-specific transcriptional repressor.
Lopez RG; Carron C; Oury C; Gardellin P; Bernard O; Ghysdael J
J Biol Chem; 1999 Oct; 274(42):30132-8. PubMed ID: 10514502
[TBL] [Abstract][Full Text] [Related]
19. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
20. TEL Induces Aggregation in Transformed Cells and Induces Tube Formation in NIH3T3-UCLA Cells.
Van Rompaey L; Holland E; Grosveld G
Biochem Biophys Res Commun; 2002 Mar; 291(4):820-8. PubMed ID: 11866439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
